Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Update on board meeting - Intimation ....

GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com Date: 11.08.2026 The General Manager – Listing, The Corporate Relations Department, BSE Limited, P J Towers, 25th Floor, Dalal Street, Mumbai – 400 001. Scrip Code: 530317 Dear Sir / Madam, Sub: Corrigendum to the Intimation letter dated 10th August, 2026 regarding the Board Meeting of Godavari Drugs Limited (the ‘Company’) – Correction of inadvertent typographical error. Ref: Our letter dated 10th August, 2026 submitted pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Scrip Code: 530317). We refer to our above-mentioned intimation letter dated 10th August, 2026, whereby we had informed you of the Board Meeting of the Company scheduled to consider and approve the Un-Audited Financial Results for the first quarter ended 30th June, 2026. In the said letter, the date of the Board Meeting was inadvertently mentioned as “Friday, August 24, 2026” in the body of the letter due to a typographical error. The correct date of the Board Meeting is Friday, 14th August, 2026, as correctly stated in the Subject line of the said letter. All other contents of our intimation letter dated 10th August, 2026 remain unchanged and shall be read accordingly. We regret the inadvertent error and request you to kindly take the above corrigendum on record. Thanking you. Yours faithfully, For Godavari Drugs Limited VENKATESH ACHANTA Company Secretary & Compliance Officer Plant : A-6/2, MIDC, Nanded - 431 603. MS, India.E-mail : nnd@godavaridrugs.comCIN:L24230TG1987PLC008016